Integrated PET/MRI and Germline Variants to Differentiate Brain Tumopr Recurrence From Iatrogenicchanges in Children

Launched by IRCCS SAN RAFFAELE · Jan 23, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to help doctors tell the difference between a child's brain tumor growing back and changes that happen from treatment, like surgery, chemotherapy, or radiation. The researchers are using advanced imaging techniques called PET/MRI scans. This is important because accurately identifying what's happening in the brain can help guide the best treatment for the child.

The trial is open to children and teenagers up to 18 years old who have been diagnosed with a brain tumor and have received standard treatments after surgery. During the study, eligible participants will undergo these advanced imaging tests to gather information that could improve how doctors manage brain tumor patients in the future. If you have a child who fits these criteria, this trial could be an opportunity to contribute to important research that may benefit many children with brain tumors.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • children and/or adolescents (≤18 years) diagnosed with brain tumor.
• • children who underwent the contemporary adjuvant therapy protocol of post-surgical chemo and radiotherapy.
• Exclusion Criteria:
• • patients \>18 years